Literature DB >> 20452785

Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).

Thorsten Steiner1, Catherine Vincent, Stephen Morris, Stephen Davis, Laura Vallejo-Torres, Michael C Christensen.   

Abstract

The value of neurosurgical interventions after spontaneous intracerebral hemorrhage (SICH) is uncertain. We evaluated clinical outcomes in patients diagnosed with SICH within 3 hours of symptom onset who underwent hematoma evacuation or external ventricular drainage (EVD) of the hematoma in the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST). FAST was a randomized, multicenter, double-blind, placebo-controlled trial conducted between May 2005 and February 2007 at 122 sites in 22 countries. Neurosurgical procedures (hematoma evacuation and external ventricular drainage) performed at any point after hospital admission were prospectively recorded. Clinical outcomes evaluated were post-SICH disability, as assessed by the modified Rankin Scale; neurologic impairment, as assessed by the National Institutes of Health Stroke Scale; and mortality at 90 days after SICH onset. The impact of neurosurgical procedures on clinical outcomes was evaluated using multivariate logistic regression analysis, controlling for relevant baseline characteristics. Fifty-five of 821 patients underwent neurosurgery. Patients who underwent hematoma evacuation or EVD were on average younger, had greater baseline neurologic impairment, and lower levels of consciousness compared with patients who did not undergo neurosurgery. After adjusting for these differences and other relevant baseline characteristics, we found that neurosurgery was generally associated with unfavorable outcomes at day 90. Among the patients who underwent hematoma evacuation, those with lobar ICH had less ICH expansion than those with deep gray matter ICH, and the smaller expansion was associated with lower mortality. ICH volume was substantially decreased in patients who underwent hematoma evacuation between 24 and 72 hours after hospital admission, and this was associated with better clinical outcome. In conclusion, a small number of patients who underwent neurosurgery in FAST exhibited no overall clinical benefit from neurosurgical intervention, although outcomes varied by type of surgery, time of surgery, and hematoma location. Our findings support the need for further research into the value of neurosurgery in patients with SICH.
Copyright © 2011 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452785     DOI: 10.1016/j.jstrokecerebrovasdis.2009.12.008

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

1.  Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage model.

Authors:  Kuan-Hung Chen; Han-Tan Chai; Kun-Chen Lin; John Y Chiang; Pei-Hsun Sung; Chih-Hung Chen; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

Review 2.  Surgical trials in intracerebral hemorrhage.

Authors:  Paul M Vespa; Neil Martin; Mario Zuccarello; Issam Awad; Daniel F Hanley
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

3.  Hemorrhagic stroke: introduction.

Authors:  Daniel F Hanley; Issam A Awad; Paul M Vespa; Neil A Martin; Mario Zuccarello
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

4.  Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome.

Authors:  Homajoun Maslehaty; Athanasios K Petridis; Harald Barth; Alexandros Doukas; Hubertus Maximilian Mehdorn
Journal:  Clin Pract       Date:  2012-05-17

5.  Atorvastatin combined with low-dose dexamethasone improves the neuroinflammation and survival in mice with intracerebral hemorrhage.

Authors:  Yiming Song; Xuanhui Liu; Jiangyuan Yuan; Zhuang Sha; Weiwei Jiang; Mingqi Liu; Yu Qian; Chuang Gao; Zhitao Gong; Hongliang Luo; Xin Zhou; Jinhao Huang; Rongcai Jiang; Wei Quan
Journal:  Front Neurosci       Date:  2022-08-22       Impact factor: 5.152

6.  External ventricular drain placement is associated with lower mortality after intracerebral hemorrhage with intraventricular hemorrhage.

Authors:  Andrew D Warren; Qi Li; Kristin Schwab; Brenna McKaig; Alexa N Goldstein; Steven M Greenberg; Anand Viswanathan; Christopher Anderson; M Edip Gurol; Aman Patel; Joshua N Goldstein
Journal:  Int J Emerg Med       Date:  2022-09-15

7.  Clinical Evaluation of Herbal Medicine (ICH-012) in Treating Acute Cerebral Haemorrhage: Safety and Efficacy from 6- to 72-Hour Time Window (CRRICHTrial-II).

Authors:  Qixin Zhang; Liling Zeng; Xiuyan Chen; Yuexiang Zhou; Baoying Gong; Haijun Li; Jianwen Guo
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-26       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.